BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
IN₹469.66m
Enterprise Value
IN₹466.60m
Revenue
IN₹283.95m

Annual balance sheet for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	—	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.45	0.376	22.8	2.55	33.3
Net Total Accounts Receivable
Net Total Receivables	71.7	205	330	383	276
Total Inventory
Total Other Current Assets
Total Current Assets	93.1	224	384	426	359
Net Property, Plant And Equipment	94.2	90	86.2	83.4	69.3
Other Long Term Assets
Total Assets	187	314	471	510	428
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.9	137	285	318	207
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	18.9	141	289	322	213
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	168	173	182	188	216
Total Liabilities & Shareholders' Equity	187	314	471	510	428
Total Common Shares Outstanding